Evidence map›Paper›PMID 34201952›Full record

ReviewInternational journal of molecular sciences2021

Flavonoids in Skin Senescence Prevention and Treatment.

Anna Domaszewska-Szostek, Monika Puzianowska-Kuźnicka, Alina Kuryłowicz

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
18.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 113 citations in OpenAlex.

  1. Trial
  2. Efficacy of MitoHealClinical and experimental dermatology · 2022
    Trial
  3. Article
  4. GC-Ms, UHPLC-MS/MSChemistry & biodiversity · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Anna Domaszewska-SzostekDepartment of Human Epigenetics, Mossakowski Medical Research Centre PAS, 02-106 Warsaw, Poland.ORCID 0000-0002-7672-1838
Monika Puzianowska-KuźnickaDepartment of Human Epigenetics, Mossakowski Medical Research Centre PAS, 02-106 Warsaw, Poland.
Alina KuryłowiczDepartment of Human Epigenetics, Mossakowski Medical Research Centre PAS, 02-106 Warsaw, Poland.ORCID 0000-0001-8632-4927
Mossakowski Medical Research Institute, Polish Academy of Sciences · PLPostgraduate School of Molecular Medicine · PL

Funding

Narodowe Centrum Nauki 2020/04/X/NZ4/02074
6 · The paper itself

Abstract

Skin aging is associated with the accumulation of senescent cells and is related to many pathological changes, including decreased protection against pathogens, increased susceptibility to irritation, delayed wound healing, and increased cancer susceptibility. Senescent cells secrete a specific set of pro-inflammatory mediators, referred to as a senescence-associated secretory phenotype (SASP), which can cause profound changes in tissue structure and function. Thus, drugs that selectively eliminate senescent cells (senolytics) or neutralize SASP (senostatics) represent an attractive therapeutic strategy for age-associated skin deterioration. There is growing evidence that plant-derived compounds (flavonoids) can slow down or even prevent aging-associated deterioration of skin appearance and function by targeting cellular pathways crucial for regulating cellular senescence and SASP. This review summarizes the senostatic and senolytic potential of flavonoids in the context of preventing skin aging.

Indexed as

AgingAnimalsCellular SenescenceFlavonoidsHumansKeratinocytesLangerhans CellsSkinSkin AgingFlavonoidsflavonoidssenescence-associated secretory phenotype (SASP)senescent cellssenolyticssenostatics

Identifiers

PMID34201952
PMCPMC8267725
OpenAlexW3176618967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.